UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial

Annals of internal medicine, 2007-03, Vol.146 (5), p.326

2007

Volltextzugriff (PDF)

Effects of an Oral Growth Hormone Secretagogue in Older Adults

The journal of clinical endocrinology and metabolism, 2009-04, Vol.94 (4), p.1198-1206

2009

Volltextzugriff (PDF)

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

The journal of clinical endocrinology and metabolism, 2003-11, Vol.88 (11), p.5212-5220

2003

Volltextzugriff (PDF)

Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia

The American journal of cardiology, 2002-11, Vol.90 (10), p.1092-1097

2002

Volltextzugriff (PDF)

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study

JAMA : the journal of the American Medical Association, 2003-04, Vol.289 (14), p.1826

2003

Volltextzugriff (PDF)

The quantum query complexity of the hidden subgroup problem is polynomial

Information processing letters, 2004-07, Vol.91 (1), p.43-48

2004

Volltextzugriff (PDF)

Medication persistence with weekly versus daily doses of orally administered bisphosphonates

Endocrine practice, 2006-09, Vol.12 (5), p.522-528

2006

Volltextzugriff (PDF)

Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women

The journal of clinical endocrinology and metabolism, 2001-05, Vol.86 (5), p.1890-1897

2001

Volltextzugriff (PDF)

Upper Gastrointestinal Tract Safety of Risedronate: A Pooled Analysis of 9 Clinical Trials

Mayo Clinic proceedings, 2002-03, Vol.77 (3), p.262-270

2002

Volltextzugriff (PDF)

How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy

The Annals of pharmacotherapy, 2006-06, Vol.40 (6), p.1143-1150

2006

Volltextzugriff (PDF)

Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE

Current medical research and opinion, 2005-03, Vol.21 (3), p.391-401

2005

Volltextzugriff (PDF)

Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age

Journal of rheumatology, 2005-10, Vol.32 (10), p.1968

2005

Volltextzugriff (PDF)

On Quantum Algorithms for Noncommutative Hidden Subgroups

Advances in applied mathematics, 2000-10, Vol.25 (3), p.239-251

2000

Volltextzugriff (PDF)

Aging bone and osteoporosis: strategies for preventing fractures in the elderly

Archives of internal medicine (1960), 2003-10, Vol.163 (18), p.2237

Ettinger, Mark P

2003

Volltextzugriff (PDF)

Improving Compliance and Persistence with Bisphosphonate Therapy for Osteoporosis

The American journal of medicine, 2006-04, Vol.119 (4), p.S18-S24

2006

Volltextzugriff (PDF)

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

Clinical therapeutics, 2000-12, Vol.22 (12), p.1433-1442

2000

Volltextzugriff (PDF)

Alendronate for the Treatment of Osteoporosis in Men

The New England journal of medicine, 2000-08, Vol.343 (9), p.604-610

2000

Volltextzugriff (PDF)

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

The journal of clinical endocrinology and metabolism, 2000-06, Vol.85 (6), p.2129-2134

2000

Volltextzugriff (PDF)

Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene

Menopause (New York, N.Y.), 2006-05, Vol.13 (3), p.377-386

2006

Volltextzugriff (PDF)

The complexity of comparing reaction systems

Bioinformatics, 2002-03, Vol.18 (3), p.465-469

ETTINGER, Mark

2002

Volltextzugriff (PDF)

Steganalysis and Game Equilibria

Information Hiding, 1998, Vol.1525, p.319-328

1998

Volltextzugriff (PDF)

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

Obstetrical & gynecological survey, 2004-05, Vol.59 (5), p.356-358

2004

Volltextzugriff (PDF)

Improving compliance and persistence with bisphosphonate therapy for osteoporosis: Improving Compliance and Persistence with Osteoporosis Therapies

The American journal of medicine, 2006, Vol.119 (4A)

2006

Volltextzugriff (PDF)

Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women

The journal of clinical endocrinology and metabolism, 2000-05, Vol.85 (5), p.1783-1788

2000

Volltextzugriff (PDF)

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

The American journal of gastroenterology, 2000-09, Vol.95 (9), p.2457-2457

2000

Volltextzugriff (PDF)

1 – 25 von 402

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(316)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(293)
Deutsch
(108)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial

Effects of an Oral Growth Hormone Secretagogue in Older Adults

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study

The quantum query complexity of the hidden subgroup problem is polynomial

Medication persistence with weekly versus daily doses of orally administered bisphosphonates

Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women

Upper Gastrointestinal Tract Safety of Risedronate: A Pooled Analysis of 9 Clinical Trials

How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy

Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE

Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age

On Quantum Algorithms for Noncommutative Hidden Subgroups

Aging bone and osteoporosis: strategies for preventing fractures in the elderly

Improving Compliance and Persistence with Bisphosphonate Therapy for Osteoporosis

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

Alendronate for the Treatment of Osteoporosis in Men

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene

The complexity of comparing reaction systems

Steganalysis and Game Equilibria

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

Improving compliance and persistence with bisphosphonate therapy for osteoporosis: Improving Compliance and Persistence with Osteoporosis Therapies

Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

Suchergebnisse filtern